Ovarian Cancer Diagnostics Industry Outlook 2025-2029: Market Set to Cross $3.93 Billion Milestone

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Ovarian Cancer Diagnostics Market Size By 2025?
The market size for ovarian cancer diagnostics has considerably expanded over the recent past. There is a projected increase from $2.74 billion in 2024 to $2.92 billion in 2025, featuring a compound annual growth rate (CAGR) of 6.6%. The noted growth during the historical period is linked to advancements in biomarker discovery and validation, uptake of transvaginal ultrasound, heightened awareness of BRCA gene mutations, studies on tumor markers, as well as screening programs and guidelines.

How Big Is the Ovarian Cancer Diagnostics Market Size Expected to Grow by 2029?
The market for ovarian cancer diagnostics is projected to witness robust expansion in the coming years. The market is estimated to reach $3.93 billion by 2029 at a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period is anticipated due to factors like early detection efforts, a rise in ovarian cancer cases, the application of artificial intelligence (AI), customized medical treatments, the discovery of new biomarkers, and genomic and proteomic profiling. The period of forecast will see key trends such as the use of biosensor technologies for early detection, incorporation of digital pathology, breakthroughs in imaging modalities, enhancement of imaging technologies, and progress in pathology techniques.

View the full report here:
https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report

Which Key Market Drivers Powering Ovarian Cancer Diagnostics Market Expansion and Growth?
The growing incidences of ovarian cancer is attributed to fuel the expansion of the ovarian cancer diagnostics market in the future. Ovarian cancer, a cancerous growth arising from the ovaries - the female reproductive glands accountable for the production of eggs and hormones. The shift towards rising cases is linked to increased life span, postponed childbearing and alterations in lifestyle. Diagnostics for ovarian cancer can play a critical role in minimizing its prevalence through enabling early recognition and subsequent intervention, facilitating prompt treatment and improved results. As an example, in 2022, the World Ovarian Cancer, a Canada-based institution focusing on advancing awareness among women affected by ovarian cancer globally revealed that by 2050, the global rate of ovarian cancer in women is anticipated to surge by over 55% and anticipated to reach about 503,448 cases. Furthermore, the annual fatalities from ovarian cancer are foreseen to escalate to 350,956, indicating nearly a 70% growth from 2022. Hence, the escalating prevalence of ovarian cancer is a key driver for the growth of the ovarian cancer diagnosis market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12022&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Ovarian Cancer Diagnostics Market?
The rise in advanced diagnostic technology is becoming a prevalent trend in the ovarian cancer diagnostics market. To maintain their market stance, companies in this sector are embracing these innovative diagnostic attributes. For instance, in November 2022, Switzerland-based pharmaceutical and healthcare firm, Hoffmann-La Roche AG, obtained FDA authorization for the VENTANA FOLR1 (FOLR1-2.1) RxDx Assay. This kit is the foremost (immunohistochemistry) IHC-based companion diagnostic device specifically formulated for identifying ovarian cancer patients suitable for ELAHERE, a prescription drug for the disease. The test is particularly aimed at providing critical insights and comprehensive clinical data on the ovarian cancer condition, consequently bolstering disease management and patient outcomes.

What Are the Emerging Segments in the Ovarian Cancer Diagnostics Market?
The ovarian cancer diagnostics market covered in this report is segmented -

1) By Product Type: Instruments, Kits, Reagents
2) By Diagnosis Type: Biopsy, Blood Test, Imaging, Other Diagnosis Types
3) By Cancer Type: Epithelial Tumor, Germ Cell Tumor, Stromal Cell Tumor, Other Cancer Types
4) By End User: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes

Subsegments:
1) By Instruments: Imaging Systems, Biopsy Devices, Molecular Diagnostic Instruments
2) By Kits: Diagnostic Test Kits, Screening Kits
3) By Reagents: Antibodies, Enzymes, Assay Reagents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12022&type=smp

Who Are the Global Leaders in the Ovarian Cancer Diagnostics Market?
Major companies operating in the ovarian cancer diagnostics market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, GE HealthCare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Bio-rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., ArcherDX Inc., Invitae Corporation, Guardant Health, Luminex Corporation, NanoString Technologies Inc., Siemens Healthcare Private Limited, Menarini Silicon Biosystems S.p.A., Precipio Inc., Angle plc

Which are the Top Profitable Regional Markets for the Ovarian Cancer Diagnostics Industry?
North America was the largest region in the ovarian cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovarian cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12022

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.